Obesity is an important risk factor for type 2 diabetes.¹ Both obesity and type 2 diabetes are risk factors for cardiovascular disease.² Weight management is a key part of the recommended care for patients with type 2 diabetes.³ Lifestyle interventions (diet and exercise) are the cornerstone of management but are not effective for all patients and other interventions, including pharmacotherapy are often required.⁴ However, approved drug treatments for type 2 diabetes can have positive and negative effects on patients’ weight.⁵

• What challenges do you face when trying to achieve weight loss in your patients who have type 2 diabetes?


• Which drugs treatments indicated for type 2 diabetes are most suitable for patients who are overweight or obese and why?

References:

1. Cameron et al. Quantifying the Sex-Race/Ethnicity-Specific Burden of Obesity on Incident Diabetes Mellitus in the United States, 2001 to 2016: MESA and NHANES. Journal of the American Heart Association. 2021 Feb 16;10(4):e018799.


2. Scherer and Hill. Obesity, Diabetes, and Cardiovascular Diseases: A Compendium. Circulation Research. 2016 May 27; 118(11): 1703–1705.


3. Davies et al. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2018; 61:2461–2498.


4. Leitner et al. Obesity and Type 2 Diabetes: Two Diseases with a Need for Combined Treatment Strategies - EASO Can Lead the Way. Obesity Facts. 2017 Nov; 10(5): 483–492.


5. Apovian et al. Body Weight Considerations in the Management of Type 2 Diabetes. Advances in Therapy. 2019; 36(1): 44–58.

Obesity is an important risk factor for type 2 diabetes.¹ Both obesity and type 2 diabetes are risk factors for cardiovascular disease.² Weight management is a key part of the recommended care for patients with type 2 diabetes.³ Lifestyle interventions (diet and exercise) are the cornerstone of management but are not effective for all patients and other interventions, including pharmacotherapy are often required.⁴ However, approved drug treatments for type 2 diabetes can have positive and negative effects on patients’ weight.⁵

• What challenges do you face when trying to achieve weight loss in your patients who have type 2 diabetes?
• Which drugs treatments indicated for type 2 diabetes are most suitable for patients who are overweight or obese and why?

References:

1. Cameron et al. Quantifying the Sex-Race/Ethnicity-Specific Burden of Obesity on Incident Diabetes Mellitus in the United States, 2001 to 2016: MESA and NHANES. Journal of the American Heart Association. 2021 Feb 16;10(4):e018799.
2. Scherer and Hill. Obesity, Diabetes, and Cardiovascular Diseases: A Compendium. Circulation Research. 2016 May 27; 118(11): 1703–1705.
3. Davies et al. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2018; 61:2461–2498.
4. Leitner et al. Obesity and Type 2 Diabetes: Two Diseases with a Need for Combined Treatment Strategies - EASO Can Lead the Way. Obesity Facts. 2017 Nov; 10(5): 483–492.
5. Apovian et al. Body Weight Considerations in the Management of Type 2 Diabetes. Advances in Therapy. 2019; 36(1): 44–58.

Obesity is an important risk factor for type 2 diabetes.¹ Both obesity and type 2 diabetes are risk factors for cardiovascular disease.² Weight management is a key part of the recommended care for patients with type 2 diabetes.³ Lifestyle interventions (diet and exercise) are the cornerstone of management but are not effective for all patients and other interventions, including pharmacotherapy are often required.⁴ However, approved drug treatments for type 2 diabetes can have positive and negative effects on patients’ weight.⁵

• What challenges do you face when trying to achieve weight loss in your patients who have type 2 diabetes?


• Which drugs treatments indicated for type 2 diabetes are most suitable for patients who are overweight or obese and why?

References:

1. Cameron et al. Quantifying the Sex-Race/Ethnicity-Specific Burden of Obesity on Incident Diabetes Mellitus in the United States, 2001 to 2016: MESA and NHANES. Journal of the American Heart Association. 2021 Feb 16;10(4):e018799.


2. Scherer and Hill. Obesity, Diabetes, and Cardiovascular Diseases: A Compendium. Circulation Research. 2016 May 27; 118(11): 1703–1705.


3. Davies et al. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2018; 61:2461–2498.


4. Leitner et al. Obesity and Type 2 Diabetes: Two Diseases with a Need for Combined Treatment Strategies - EASO Can Lead the Way. Obesity Facts. 2017 Nov; 10(5): 483–492.


5. Apovian et al. Body Weight Considerations in the Management of Type 2 Diabetes. Advances in Therapy. 2019; 36(1): 44–58.